Journal Watch · Frontiers in Immunology · 2026
Histone modifications in laryngeal squamous cell carcinoma: from epigenetic reprogramming to precision therapy.
This study systematically summarizes recent advances in histone acetylation, methylation, lactylation, and other novel histone modifications in LSCC, further discusses crosstalk among different histone modifications and their potential roles in the tumor microenvironment and resistance to radiotherapy, chemotherapy, and immunotherapy, and analyzes therapeutic strategies targeting histone modifications as well as future prospects for single-cell and spatial epigenomics in precision medicine for LSCC, aiming to provide new theoretical foundations for biomarker development and epigenetic-targeted therapies in LSCC.
TL;DR
This study systematically summarizes recent advances in histone acetylation, methylation, lactylation, and other novel histone modifications in LSCC, further discusses crosstalk among different histone modifications and their potential roles in the tumor microenvironment and resistance to radiotherapy, chemotherapy, and immunotherapy, and analyzes therapeutic strategies targeting histone modifications as well as future prospects for single-cell and spatial epigenomics in precision medicine for LSCC, aiming to provide new theoretical foundations for biomarker development and epigenetic-targeted therapies in LSCC.
Key findings
- Histone post-translational modifications, as a crucial regulatory layer linking intracellular metabolic states, oncogenic signaling, and transcriptional programs, participate in tumor cell proliferation, epithelial-mesenchymal transition, stemness maintenance, metabolic reprogramming, and therapeutic resistance by modulating chromatin conformation, transcription factor accessibility, and gene expression profiles.
- This study systematically summarizes recent advances in histone acetylation, methylation, lactylation, and other novel histone modifications in LSCC, further discusses crosstalk among different histone modifications and their potential roles in the tumor microenvironment and resistance to radiotherapy, chemotherapy, and immunotherapy, and analyzes therapeutic strategies targeting histone modifications as well as future prospects for single-cell and spatial epigenomics in precision medicine for LSCC, aiming to provide new theoretical foundations for biomarker development and epigenetic-targeted therapies in LSCC.
What they did
Its development involves complex interactions between genetic and epigenetic alterations.
Full abstract (original)
Background: Laryngeal squamous cell carcinoma (LSCC) is a common malignancy of the head and neck, accounting for the vast majority of laryngeal cancers.
What they did: Its development involves complex interactions between genetic and epigenetic alterations.
Results & conclusions: Histone post-translational modifications, as a crucial regulatory layer linking intracellular metabolic states, oncogenic signaling, and transcriptional programs, participate in tumor cell proliferation, epithelial-mesenchymal transition, stemness maintenance, metabolic reprogramming, and therapeutic resistance by modulating chromatin conformation, transcription factor accessibility, and gene expression profiles. This study systematically summarizes recent advances in histone acetylation, methylation, lactylation, and other novel histone modifications in LSCC, further discusses crosstalk among different histone modifications and their potential roles in the tumor microenvironment and resistance to radiotherapy, chemotherapy, and immunotherapy, and analyzes therapeutic strategies targeting histone modifications as well as future prospects for single-cell and spatial epigenomics in precision medicine for LSCC, aiming to provide new theoretical foundations for biomarker development and epigenetic-targeted therapies in LSCC.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1981328 · PubMed 42923756.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
This study systematically summarizes recent advances in histone acetylation, methylation, lactylation, and other novel histone modifications in LSCC, further discusses crosstalk among different histone modifications and their potential roles in the tumor microenvironment and resistance to radiotherapy, chemotherapy, and immunotherapy, and analyzes therapeutic strategies targeting histone modifications as well as future prospects for single-cell and spatial epigenomics in precision medicine for LSCC, aiming to provide new theoretical foundations for biomarker development and epigenetic-targeted therapies in LSCC.
What type of study is this?
It is a genomics / omics study, published in Frontiers in Immunology in 2026. Its development involves complex interactions between genetic and epigenetic alterations.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1981328. PubMed ID: 42923756. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/histone-modifications-in-laryngeal-squamous-cell-carcinoma-from-epigenet-981328/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides